These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus. Sato E; Yokoyama N; Maeda K; Inoshima Y; Kohmoto M; Ikeda Y; Miyazawa T; Mikami T Arch Virol; 1998; 143(3):453-66. PubMed ID: 9572547 [TBL] [Abstract][Full Text] [Related]
27. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Ghiasi H; Nesburn AB; Kaiwar R; Wechsler SL Arch Virol; 1991; 121(1-4):163-78. PubMed ID: 1662037 [TBL] [Abstract][Full Text] [Related]
28. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Luo L; Li Y; Cannon PM; Kim S; Kang CY Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241 [TBL] [Abstract][Full Text] [Related]
29. Molecular subtyping of feline immunodeficiency virus from cats in Melbourne. Iwata D; Holloway SA Aust Vet J; 2008 Oct; 86(10):385-9. PubMed ID: 18826508 [TBL] [Abstract][Full Text] [Related]
30. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats. Greene WK; Meers J; del Fierro G; Carnegie PR; Robinson WF Arch Virol; 1993; 133(1-2):51-62. PubMed ID: 8240017 [TBL] [Abstract][Full Text] [Related]
31. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629 [TBL] [Abstract][Full Text] [Related]
32. Further development of a recombinant feline herpesvirus type 1 expressing the Gag protein of feline immunodeficiency virus. Sato E; Miyazawa T; Nishimura Y; Ikeda Y; Kawakami K; Mochizuki M; Yokoyama N; Maeda K; Fujita K; Kohmoto M; Takahashi E; Mikami T Arch Virol; 2001; 146(2):379-87. PubMed ID: 11315645 [TBL] [Abstract][Full Text] [Related]
33. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. Flynn JN; Cannon CA; Neil JC; Jarrett O J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839 [TBL] [Abstract][Full Text] [Related]
34. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties. Pancino G; Castelot S; Sonigo P Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093 [TBL] [Abstract][Full Text] [Related]
35. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents. Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. Siebelink KH; Tijhaar E; Huisman RC; Huisman W; de Ronde A; Darby IH; Francis MJ; Rimmelzwaan GF; Osterhaus AD J Virol; 1995 Jun; 69(6):3704-11. PubMed ID: 7745719 [TBL] [Abstract][Full Text] [Related]
37. Expression of feline immunodeficiency virus gag gene in Escherichia coli. Furuya T; Hasegawa A; Saitoh M; Miyazawa T; Tohya Y; Hayami M; Takahashi E; Miki K; Mikami T Arch Virol; 1992; 122(3-4):383-90. PubMed ID: 1309999 [TBL] [Abstract][Full Text] [Related]